4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-26-048919
President and CEO sold 2,500 shares at an average $547.30 ($1,368,253)
- President and CEO acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sibold William John President and CEO | 2026-07-17 | Option exercise | +50,000 | 211,829 | D | ||
| Sibold William John President and CEO | 2026-07-20 | Sale | −140 | $542.75 | $75,984 | 211,689 | D |
| Sibold William John President and CEO | 2026-07-20 | Sale | −110 | $543.79 | $59,817 | 211,579 | D |
| Sibold William John President and CEO | 2026-07-20 | Sale | −545 | $544.71 | $296,869 | 211,034 | D |
| Sibold William John President and CEO | 2026-07-20 | Sale | −275 | $545.71 | $150,070 | 210,759 | D |
| Sibold William John President and CEO | 2026-07-20 | Sale | −269 | $547.08 | $147,164 | 210,490 | D |
| Sibold William John President and CEO | 2026-07-20 | Sale | −680 | $547.70 | $372,435 | 209,810 | D |
| Sibold William John President and CEO | 2026-07-20 | Sale | −47 | $548.87 | $25,797 | 209,763 | D |
| Sibold William John President and CEO | 2026-07-20 | Sale | −153 | $550.01 | $84,152 | 209,610 | D |
| Sibold William John President and CEO | 2026-07-20 | Sale | −1 | $550.72 | $551 | 209,609 | D |
| Sibold William John President and CEO | 2026-07-20 | Sale | −280 | $555.05 | $155,414 | 209,329 | D |
| Derivatives | |||||||
| Sibold William John President and CEO | 2026-07-17 | Option exercise · Performance Restricted Stock Units | −50,000 | 0 | D | ||
| Open-market sales · 2,500 sh · avg $547.30 · $1,368,253 | |||||||
Loading xslF345X06/wk-form4_1784596610.xml…